As of 01 Jul, 2025, Concord Biotech share price is ₹1800.5. The stock opened at ₹1848.7 and had closed at ₹1839.6 the previous day. During today’s trading session, Concord Biotech share price moved between ₹1,798.00 and ₹1,848.90, with an average price for the day of ₹1823.45. Over the last 52 weeks, the stock has recorded a low of ₹1,345.00 and a high of ₹2,664.00. In terms of performance, Concord Biotech share price has declined by 18.6% over the past six months and has increased by 19.34% over the last year.
Market Cap (in crs)
19,245.20
Face Value
1
Turnover (in lacs)
722.02
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
429.88 Cr | 244.22 Cr | 310.18 Cr | 215.8 Cr | 318.97 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
1244.53 Cr | 1050.72 Cr | 888.48 Cr | 736.35 Cr |
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
141.94 Cr | 74.09 Cr | 98.7 Cr | 58.24 Cr | 97.21 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
372.96 Cr | 304.73 Cr | 238.13 Cr | 178.57 Cr |
Concord Biotech Ltd reported a 27.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 15.8%.
Its expenses for the quarter were up by 24.6% QoQ and 25.0% YoY.
The net profit increased 25.2% QoQ and increased 3.9% YoY.
The earnings per share (EPS) of Concord Biotech Ltd stood at 9.1 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 76097 Rs | 137473 Rs |
Week Rs | 118864 Rs | 186874 Rs |
Month Rs | 135998 Rs | 256671 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103.07 | 219.98 | 83 | 144.5 | 104.55 | 3.70% | 3.68% | -17.36% | 21.83% | 73.27% | 0.00% | 11.16 | 42.56 | 1.21 | |
362.45 | 47,555.80 | 291 | 404.7 | 355.70 | 3.75% | 7.88% | -1.76% | 1.30% | 16.29% | 0.32% | 0.00 | 42.56 | 2.97 | |
411.40 | 2,612.96 | 130 | 581.9 | 426.60 | -1.42% | -22.64% | -6.62% | 204.16% | 220.00% | 0.00% | 0.00 | 42.56 | 8.31 | |
37.05 | 68.00 | 31.2 | 56.9 | 37.00 | 0.52% | -2.29% | -0.80% | -8.20% | 23.91% | 0.00% | 8.98 | 42.56 | 0.89 | |
23.75 | 103.42 | 19 | 35.88 | 23.95 | -1.12% | -6.57% | -2.33% | -17.74% | -14.87% | 0.00% | 0.00 | 42.56 | -3.18 | |
325.50 | 3,596.98 | 257.9 | 571 | 321.50 | -0.64% | 7.06% | -6.84% | -12.99% | 23.90% | 1.62% | 35.14 | 42.56 | 5.72 |
Concord Biotech share price is ₹1798.6 in NSE and ₹1801.65 in BSE as on 1/7/2025.
Concord Biotech share price in the past 1-year return was 17.83. The Concord Biotech share hit a 1-year low of Rs. 1345 and a 1-year high of Rs. 2664.
The market cap of Concord Biotech is Rs. 19245.2 Cr. as of 1/7/2025.
The PE ratios of Concord Biotech is 51.86 as of 1/7/2025.
The PB ratios of Concord Biotech is 10.67 as of 1/7/2025
The Mutual Fund Shareholding in Concord Biotech was 5.16% at the end of 1/7/2025.
You can easily buy Concord Biotech shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Concord Biotech share price is ₹2664 and ₹1345 as of 1/7/2025.
Please be aware that Concord Biotech stock prices are subject to continuous fluctuations due to various factors.